Last update 17 Nov 2024
HNC664
Last update 17 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms HNC 664, HNC-664 |
Target |
Mechanism autotaxin inhibitors(Ectonucleotide pyrophosphatase/phosphodiesterase 2 inhibitors) |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with HNC664评价HNC664胶囊单药在晚期实体瘤患者中的安全性、耐受性和药代动力学特征以及联合一线标准治疗扩展的Ib期临床研究
[Translation] A Phase Ib clinical study to evaluate the safety, tolerability and pharmacokinetic characteristics of HNC664 capsules as a single agent in patients with advanced solid tumors and to expand its combination with first-line standard treatment
A Randomized, Double-blind, Placebo-controlled, Sequential Parallel Group, Single Ascending Doses (SAD) Study Following Oral Administration in Healthy Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of HNC664
100 Clinical Results associated with HNC664
Login to view more data
100 Translational Medicine associated with HNC664
Login to view more data
100 Patents (Medical) associated with HNC664
Login to view more data
100 Deals associated with HNC664
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | CN | 27 Oct 2022 | |
| Pancreatic Cancer | Phase 1 | CN | 27 Oct 2022 | |
| Idiopathic Pulmonary Fibrosis | IND Application | CN | 29 Aug 2020 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free